JBF Capital’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

JBF Capital’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-43,998	Closed	-$79.6K	–	79
2023 Q2	$79.6K	Buy	+43,998	New	+$80.4K	0.02%	68

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

JBF Capital's PRDS Position: Q3 2023 in Review

JBF Capital sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 43,998 shares — an estimated $79.6K sold.

JBF Capital first reported a position in PRDS in Q2 2023 and held it in 1 quarter. The position peaked at $79.6K in Q2 2023. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

JBF Capital reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
JBF Capital sold 43,998 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $79.6K.
JBF Capital first reported a position in Pardes Biosciences, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
JBF Capital's Pardes Biosciences, Inc. Common Stock position peaked at $79.6K in Q2 2023.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on JBF Capital's 13F filing for Q3 2023, filed 14 Nov 2023.